Legend Biotech Exceeds Earnings Expectations
Legend Biotech reports better-than-expected quarterly earnings, $0.49 EPS above estimates, with significant revenue growth.
- Latest
- Trending
Legend Biotech reports better-than-expected quarterly earnings, $0.49 EPS above estimates, with significant revenue growth.
Analysts upgrade Nvidia, downgrade Intel and SMCI, while Citi favors Micron for its DRAM growth.
SciVision Biotech reports a 33% net income increase in Q2 2024, EPS rises to NT$1.00 boosting investor confidence.
Catcher Technology surpasses earnings forecasts with NT$4.7b revenue, boosting investor confidence.
Discover why ServiceNow, Inc. (NOW) is a top AI stock pick with strong growth potential, recommended by financial media.
Marvell Technology's AI potential and projections make it a stock to watch, despite mixed Q1 results and market competition.
ETFSwap predicted to rise 10,000% in 13 days, shifting focus from memecoins.
RioCan achieves 98.3% occupancy, 52.5% lease spread. Focused on strong tenants, debt reduction as COVID-19 impacts ease.
Cetera Investment Advisers increased AI ETF holdings by 1,115.3% in Q1, owning 0.64% of the fund valued at $3,637,000.
SmartCentres REIT shows robust Q2 results with 98.2% occupancy and strategic developments, aiming for a lower payout ratio.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.